Ascendis Pharma As Stock Alpha and Beta Analysis
| ASND Stock | USD 130.85 1.04 0.80% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Ascendis Pharma AS. It also helps investors analyze the systematic and unsystematic risks associated with investing in Ascendis Pharma over a specified time horizon. Remember, high Ascendis Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Ascendis Pharma's market risk premium analysis include:
Beta 0.84 | Alpha (0.17) | Risk 3.38 | Sharpe Ratio (0.01) | Expected Return (0.04) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Ascendis |
Ascendis Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Ascendis Pharma market risk premium is the additional return an investor will receive from holding Ascendis Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ascendis Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Ascendis Pharma's performance over market.| α | -0.17 | β | 0.84 |
Ascendis Pharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Ascendis Pharma's Buy-and-hold return. Our buy-and-hold chart shows how Ascendis Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Ascendis Pharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Ascendis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascendis Pharma shares will generate the highest return on investment. By understating and applying Ascendis Pharma stock market price indicators, traders can identify Ascendis Pharma position entry and exit signals to maximize returns.
Ascendis Pharma Return and Market Media
The median price of Ascendis Pharma for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 129.36 with a coefficient of variation of 7.6. The daily time series for the period is distributed with a sample standard deviation of 10.02, arithmetic mean of 131.85, and mean deviation of 8.38. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Exploring Three High Growth Tech Stocks For Your Portfolio | 09/05/2024 |
2 | High Growth Tech Stocks To Watch For Potential Robust Returns | 09/17/2024 |
3 | Heres How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years | 10/08/2024 |
4 | Novo Nordisk Q3 Preview Will 285 Million Weight Loss Bet Offset Bearish Charts | 11/05/2024 |
5 | Heres Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical | 11/07/2024 |
6 | Ascendis Pharma Q3 2024 Earnings Preview | 11/13/2024 |
7 | T. Rowe Price Investment Management, Inc. Expands Holdings in Ascendis Pharma AS | 11/14/2024 |
8 | Oppenheimer cuts Ascendis Pharma stock target, outperform on Q3 report | 11/15/2024 |
9 | Ascendis Pharmas SWOT analysis stock faces growth hurdles amid pipeline promise - Investing.com India | 11/22/2024 |
About Ascendis Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Ascendis or other stocks. Alpha measures the amount that position in Ascendis Pharma AS has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.0593 | 0.12 | 0.47 | 0.49 | Days Of Inventory On Hand | 7.8K | 3.9K | 1.7K | 1.6K |
Ascendis Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Ascendis Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ascendis Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Ascendis Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Ascendis Pharma. Please utilize our Beneish M Score to check the likelihood of Ascendis Pharma's management manipulating its earnings.
| 15th of February 2024 Upcoming Quarterly Report | View | |
| 25th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 15th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Ascendis Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Ascendis Pharma Backtesting, Ascendis Pharma Valuation, Ascendis Pharma Correlation, Ascendis Pharma Hype Analysis, Ascendis Pharma Volatility, Ascendis Pharma History and analyze Ascendis Pharma Performance. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Ascendis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.